Biopharmaceutical Pipeline: Highly Innovative Products Designed to Save Lives
A1 Gene, Inc.'s biopharmaceutical pipeline contains innovative and significant treatments that can potentially address a number of health conditions, including cancer. These products are currently in the preclinical stage of development.
Indication: Cancer
A1 Gene, Inc. is developing a mutant plasmid cDNA for the A1 adenosine receptor for a cancer treatment. When this treatment was administered as an intratumor injection in mice with prostate cancer, the tumor volume was reduced by 87 percent.
- Compound: Mutant plasmid cDNA
- Indication: Cancer
- Mechanism of Action: Protein Correction
- Formulation: Intratumor
- Phase of Development: Preclinical